FTSE All-Share
|
4 925,46
|
20,09
|
0,41 %
|
Analysen zu FTSE All-Share-Werten
| 08.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 08.02.24 | Unilever Sector Perform | RBC Capital Markets | |
| 07.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 07.02.24 | BP Buy | UBS AG | |
| 07.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 07.02.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 06.02.24 | BP Overweight | Barclays Capital | |
| 06.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 06.02.24 | BP Outperform | RBC Capital Markets | |
| 06.02.24 | BP Hold | Jefferies & Company Inc. | |
| 06.02.24 | GSK Buy | UBS AG | |
| 06.02.24 | Vodafone Group Buy | UBS AG | |
| 06.02.24 | BP Buy | UBS AG | |
| 05.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 05.02.24 | Shell Buy | Jefferies & Company Inc. | |
| 05.02.24 | BP Outperform | RBC Capital Markets | |
| 05.02.24 | Vodafone Group Buy | Deutsche Bank AG | |
| 05.02.24 | GSK Buy | Deutsche Bank AG | |
| 05.02.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 05.02.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 05.02.24 | National Grid Buy | Jefferies & Company Inc. | |
| 02.02.24 | Glencore Equal Weight | Barclays Capital | |
| 02.02.24 | GSK Equal Weight | Barclays Capital | |
| 02.02.24 | HSBC Holdings Overweight | Barclays Capital | |
| 02.02.24 | Shell Outperform | RBC Capital Markets | |
| 01.02.24 | Shell Buy | Jefferies & Company Inc. | |
| 01.02.24 | Diageo Underperform | RBC Capital Markets | |
| 01.02.24 | Glencore Buy | Jefferies & Company Inc. | |
| 01.02.24 | Shell Overweight | Barclays Capital | |
| 01.02.24 | Unilever Overweight | Barclays Capital | |
| 01.02.24 | GSK Halten | DZ BANK | |
| 01.02.24 | Glencore Outperform | RBC Capital Markets | |
| 01.02.24 | Shell Outperform | RBC Capital Markets | |
| 01.02.24 | Shell Neutral | UBS AG | |
| 01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Buy | UBS AG | |
| 31.01.24 | AstraZeneca Sell | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
| AstraZeneca | 3 |
| Rio Tinto | 2 |
| HSBC Holdings | 2 |
| GSK | 2 |
| BP | 2 |
| Unilever | 2 |
| London Stock Exchange | 1 |
| National Grid | 1 |
| BAT | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.